Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OTOV-101 by Suzhou Otovia Therapeutics for Deafness: Likelihood of Approval
OTOV-101 is under clinical development by Suzhou Otovia Therapeutics and currently in Phase I for Deafness. According to GlobalData, Phase...